Department of Clinical Neurosciences and Preventive Medicine, University of Continuing Education Krems, Krems, Austria.
Nursing and Allied Health Profession Office, Physiotherapy Occupational Therapy, University Hospital Zurich, Zurich, Switzerland.
J Intensive Care Med. 2024 Jun;39(6):534-541. doi: 10.1177/08850666231217679. Epub 2023 Nov 28.
Femoral cannulated extracorporeal membrane oxygenation (ECMO) has been associated with neurologic complications in the lower extremity ipsilateral to the cannulation. There is uncertainty about the prevalence of these complications and their mechanisms of development.
Aim of this systematic review was to investigate the prevalence of neurological complications after ECMO and to describe possible underlying mechanisms.
A systematic literature search was performed in Medline-Ovid, Embase, Cochrane Library, CINAHL, and PEDro until April 2021 for clinical trials in English or German language which quantified neurologic complications in the lower extremity ipsilateral to the ECMO cannulation of adults. The complications had to be delimitable to intensive care unit-acquired weakness. Methodological quality was assessed by 2 independent investigators using the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies of the National Heart, Lung, and Blood Institute.
Eight observational studies were included in the synthesis. Study quality was good to fair in 88% of the papers. Overall, 47 of 202 patients (23.3%; ranging from 3% to 48% across studies) with femoral ECMO cannulation showed neurologic complications of the lower extremity ipsilateral to the cannulation. Peripheral ischemia and compression of nerves by the ECMO cannula are discussed as mechanisms of injury.
The occurrence of neurological complications after ECMO was common and can lead to long-term impairment. The mechanisms are largely unknown but currently there is no sufficient evidence for the involvement of ECMO. Standardized assessments are needed to systematically screen for neurological complications early after ECMO, to enable countermeasures and prevent further complications.
股静脉体外膜肺氧合(ECMO)与插管侧下肢的神经并发症有关。这些并发症的发生率及其发生机制尚不确定。
本系统评价旨在调查 ECMO 后神经系统并发症的发生率,并描述可能的潜在机制。
系统检索了 Medline-Ovid、Embase、Cochrane 图书馆、CINAHL 和 PEDro 中的英文或德文临床试验,检索时间截至 2021 年 4 月,以评估成人 ECMO 插管对侧下肢的神经并发症。并发症必须是可定义为 ICU 获得性肌无力。2 名独立研究者使用美国国立心肺血液研究所的观察性队列研究和横断面研究质量评估工具对方法学质量进行了评估。
共有 8 项观察性研究纳入综合分析。88%的研究质量为良好至中等。总体而言,202 例股静脉 ECMO 插管患者中有 47 例(占 23.3%;各研究中范围为 3%至 48%)出现插管对侧下肢神经系统并发症。周围缺血和 ECMO 插管对神经的压迫被认为是损伤的机制。
ECMO 后神经系统并发症的发生率较高,可导致长期残疾。其机制在很大程度上尚不清楚,但目前尚无充分证据表明 ECMO 参与其中。需要进行标准化评估,以便在 ECMO 后早期系统筛查神经系统并发症,从而采取对策并预防进一步的并发症。